142 results
Page 3 of 8
8-K
EX-99.1
mjzxl3wc 664wwxb
29 Dec 15
NW Bio Announces a Registered Direct Offering of $12.6 Million
12:00am
8-K
EX-10.1
g0muck7uy
29 Dec 15
NW Bio Announces a Registered Direct Offering of $12.6 Million
12:00am
8-K
EX-10.3
nxvc6xolcw4sigrrmxhf
29 Dec 15
NW Bio Announces a Registered Direct Offering of $12.6 Million
12:00am
424B5
pwmqahkjiqe z14l
24 Dec 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
j9ktg2ehn1 92
10 Oct 14
NW Bio Announces $11.5 Million Financing
12:00am
424B5
g8lux9fnikt0o87
8 Oct 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
b5xjk9pyqi8jvbys
18 Sep 14
NW Bio’s Cancer Vaccine Is the First Drug to Be Designated
12:00am
8-K
EX-99.1
z80nrw9594
11 Aug 14
NW BIO Obtains Approvals for Enhancements of Phase III Trial of
12:00am
8-K
EX-99.2
jd9z4jul w2
11 Aug 14
NW BIO Obtains Approvals for Enhancements of Phase III Trial of
12:00am
8-K
EX-10.2
b887q9g
14 Apr 14
NW Bio Announces Financing of Up to $32 Million
12:00am